Insider · CIK 0001990498
Ehong Gu
Files at LIANY (LianBio). First filing Apr 11, 2024, latest Apr 11, 2024.
In brief
Ehong Gu files SEC Form 4 as CFO at LIANY (LianBio). Since Apr 11, 2024, Ehong Gu has reported 0 open-market buys worth $0 and 1 open-market sell worth $7,513, the latest filed on Apr 11, 2024.
A track record needs three past buys with six months of prices behind them; Ehong Gu has 0, so none is measured yet.
The newest scored trade: sold $7,513 of LIANY on Jan 2, 2024, filed Apr 11, 2024, scored 22 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LIANY: LianBio
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | LIANYsell LianBio | $7,513 1,731 shares | -2% | -5% from low+229% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | LIANY LianBio | SOpen-market sale Ordinary Shares | -1,731 | $4.34 | $7,513 | 76,762 | Apr 11, 2024 |
| Apr 9, 2024 | LIANY LianBio | DDisposition to issuer Ordinary Shares | -17,889 | $0.32 | $5,724 | 0 | Apr 11, 2024 |
Questions about Ehong Gu
Answered from the filings on this page, as of the latest one.
Is Ehong Gu buying or selling?
Not in the last 12 months. Ehong Gu's latest open-market trade on SEC Form 4 was sold $7,513 of LIANY on Jan 2, 2024.
How did Ehong Gu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ehong Gu has 0.
Where does Ehong Gu file Form 4?
Ehong Gu has filed Form 4 at LIANY (LianBio) as Interim CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.